Byrne, Jo L.
Dallosso, Helen M.
Rogers, Stephen
Gray, Laura J.
Waheed, Ghazala
Patel, Prashanth
Gupta, Pankaj
Doherty, Yvonne
Davies, Melanie J.
Khunti, Kamlesh
Funding for this research was provided by:
Collaboration for Leadership in Applied Health Research and Care - Greater Manchester
Article History
Received: 4 March 2020
Accepted: 11 June 2020
First Online: 27 July 2020
Ethics approval and consent to participate
: This study was approved by the Health Research Authority East Midlands-Leicester South Research Ethics Committee (15/EM/0472). All participants gave informed consent before taking part.
: No support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years, and no other relationships or activities that could appear to have influenced the submitted work. KK reports personal fees from Amgen, AstraZeneca, Bayer, NAPP, Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche, Berlin-Chemie AG/Menarini Group, Sanofi-Aventis, Servier and Boehringer Ingelheim, and grants from Pfizer, Boehringer Ingelheim, AstraZeneca, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, and Servier, outside the submitted work.